Medco Expanding Part D Program In 2008 With Three Plans
Executive Summary
Medco is broadening its stake in the Medicare Part D market for 2008 with the introduction of three of its own stand-alone drug plans nationwide
You may also be interested in...
Medco Takes Mail To The Next Level With Free Therapeutic Resource Centers
Medco's therapeutic resource centers may provide the answer to disease management in the mail-order setting by enhancing patient care to levels previously limited to retail
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.